Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.

Shirakata Y, Shiragami C, Yamashita A, Nitta E, Fujiwara A, Shiraga F.

Jpn J Ophthalmol. 2012 Nov;56(6):599-607. doi: 10.1007/s10384-012-0183-y. Epub 2012 Sep 19.

PMID:
22990616
[PubMed - indexed for MEDLINE]
2.

Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.

Saito M, Shiragami C, Shiraga F, Kano M, Iida T.

Am J Ophthalmol. 2010 Mar;149(3):472-81.e1. doi: 10.1016/j.ajo.2009.09.016. Epub 2010 Jan 6.

PMID:
20053392
[PubMed - indexed for MEDLINE]
3.

Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration.

Yoshizawa C, Saito W, Hirose S, Kitamei H, Noda K, Ishida S.

Jpn J Ophthalmol. 2013 Jan;57(1):68-73. doi: 10.1007/s10384-012-0206-8. Epub 2012 Oct 24.

PMID:
23093314
[PubMed - indexed for MEDLINE]
4.

Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation.

Saito M, Iida T, Kano M.

Jpn J Ophthalmol. 2013 Mar;57(2):211-20. doi: 10.1007/s10384-012-0215-7. Epub 2012 Dec 4.

PMID:
23208024
[PubMed - indexed for MEDLINE]
5.

[Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].

Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C.

J Fr Ophtalmol. 2011 Jun;34(6):376-81. doi: 10.1016/j.jfo.2011.03.004. Epub 2011 May 7. French.

PMID:
21550687
[PubMed - indexed for MEDLINE]
Free Article
6.

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):779-84. doi: 10.1007/s00417-010-1302-4. Epub 2010 Feb 19.

PMID:
20169357
[PubMed - indexed for MEDLINE]
7.

Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.

Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92. doi: 10.1007/s00417-012-1955-2. Epub 2012 Feb 21.

PMID:
22350060
[PubMed - indexed for MEDLINE]
8.

Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.

Hatta Y, Ishikawa K, Nishihara H, Ozawa S, Ito Y, Terasaki H.

Retina. 2010 Mar;30(3):495-502. doi: 10.1097/IAE.0b013e3181bcedbe.

PMID:
19996828
[PubMed - indexed for MEDLINE]
9.

Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.

Saito M, Iida T, Kano M.

Am J Ophthalmol. 2012 Mar;153(3):504-514.e1. doi: 10.1016/j.ajo.2011.08.038. Epub 2011 Nov 10.

PMID:
22078902
[PubMed - indexed for MEDLINE]
10.

A retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration.

Kovacs KD, Quirk MT, Kinoshita T, Gautam S, Ceron OM, Murtha TJ, Arroyo JG.

Retina. 2011 Mar;31(3):446-52. doi: 10.1097/IAE.0b013e3181f6391f.

PMID:
21336068
[PubMed - indexed for MEDLINE]
11.

Visual and morphological outcomes of bevacizumab (AvastinĀ®) versus ranibizumab (LucentisĀ®) treatment for retinal angiomatous proliferation.

Hufendiek K, Hufendiek K, Panagakis G, Helbig H, Gamulescu MA.

Int Ophthalmol. 2012 Jun;32(3):259-68. doi: 10.1007/s10792-012-9562-0. Epub 2012 Apr 18.

PMID:
22527448
[PubMed - indexed for MEDLINE]
12.

Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.

Sagong M, Lim S, Chang W.

Am J Ophthalmol. 2012 May;153(5):873-882.e2. doi: 10.1016/j.ajo.2011.09.031. Epub 2012 Jan 20.

PMID:
22265146
[PubMed - indexed for MEDLINE]
13.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
[PubMed - indexed for MEDLINE]
14.

Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study.

Lim JY, Lee SY, Kim JG, Lee JY, Chung H, Yoon YH.

Acta Ophthalmol. 2012 Feb;90(1):61-7. doi: 10.1111/j.1755-3768.2009.01841.x. Epub 2010 Mar 16.

PMID:
20337606
[PubMed - indexed for MEDLINE]
15.

Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.

Ahmadieh H, Taei R, Riazi-Esfahani M, Piri N, Homayouni M, Daftarian N, Yaseri M.

Retina. 2011 Oct;31(9):1819-26. doi: 10.1097/IAE.0b013e31820d58f2.

PMID:
21555967
[PubMed - indexed for MEDLINE]
16.

Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.

Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA, Yannuzzi LA.

Arch Ophthalmol. 2006 Apr;124(4):487-92.

PMID:
16606873
[PubMed - indexed for MEDLINE]
17.

Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.

Saito M, Shiragami C, Shiraga F, Nagayama D, Iida T.

Am J Ophthalmol. 2008 Dec;146(6):935-41.e1. doi: 10.1016/j.ajo.2008.06.033. Epub 2008 Aug 23.

PMID:
18723139
[PubMed - indexed for MEDLINE]
18.

Comparison of different treatment intervals between bevacizumab injection and photodynamic therapy in combined therapy for age-related macular degeneration.

Sawa M, Iwata E, Ishikawa K, Gomi F, Nishida K, Terasaki H.

Jpn J Ophthalmol. 2012 Sep;56(5):470-5. doi: 10.1007/s10384-012-0154-3. Epub 2012 Jun 9.

PMID:
22678809
[PubMed - indexed for MEDLINE]
19.

Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.

Lo Giudice G, Gismondi M, De Belvis V, Cian R, Tavolato M, Galan A.

Retina. 2009 Jul-Aug;29(7):949-55. doi: 10.1097/IAE.0b013e3181af106d.

PMID:
19584653
[PubMed - indexed for MEDLINE]
20.

Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.

Ricci F, Calabrese A, Regine F, Missiroli F, Ciardella AP.

Retina. 2012 Jul;32(7):1280-8. doi: 10.1097/IAE.0b013e318236e835.

PMID:
22218148
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk